1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 03 NOVEMBER 2014

Key Pharma News 03 NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 27 pages

Industry Trend Analysis - Roche's Oncology Portfolio Reinforcement Securing Growth
Industry Trend Analysis - BMS Fortifies Immuno-Oncology Pipeline With Acquisition Option
Industry Trend Analysis - Roche Bets On NewLink With USD1bn Deal
Industry Brief - Pharmacyclics/Roche Enter Deal To Evaluate Imbruvica/Gazyva In Lymphoma And Leukaemia
Industry Brief - Astellas/CoMentis To End Alzheimer's Collaboration
Industry Brief - Bavarian Nordic/Janssen Enter Agreement For MVA-BN Ebola Vaccine
Industry Trend Analysis - Enanta And AbbVie Each Faced With Pivotal HCV Decisions
Industry Trend Analysis - Next-Generation Antibodies Instigate New Wave Of Collaborations
Industry Trend Analysis - Ventana Secures Further Companion Diagnostic Partnership
Industry Trend Analysis - Celgene Invests In Future With USD1bn Sutro Deal
Industry Brief - Takeda Exercises Option For Novel Fleximer ADC
Industry Brief - Takeda/Sucampo Sign Global Licensing Deal For Amitiza
Industry Brief - AbbVie/Shire Agree To Terminate Proposed Merger
Industry Trend Analysis - CSL To Overtake Key Flu Vaccine Players After Acquisition
Industry Brief - Actavis Signs Option To Acquire Rhythm Health And Worldwide Rights To Relamorelin
Industry Brief - Zogenix Acquires UK-Based Brabant Pharma
Industry Trend Analysis - Mylan Determines To Pursue Redomiciling
Industry Trend Analysis - Pfizer's Embeda Taps Into Growing Need For Abuse-Deterrent Opioids
Industry Trend Analysis - Lynparza Likely To Be First Approved PARP Inhibitor
Industry Brief - Health Canada Issues Notice Of Compliance For Gilead's Harvoni
Industry Trend Analysis - Imbruvica Has A Fighting Chance In CLL Market
Industry Brief - FDA Accepts NDA Filing For Empagliflozin/Metformin FDC
Industry Trend Analysis - Aripiprazole Lauroxil Has Potential To Fuel Future Growth For Alkermes
Industry Brief - Contrave Available In US Pharmacies
Industry Brief - FDA Accepts BLA For Merck/Sanofi Pasteur's Paediatric Hexavalent Vaccine
Industry Trend Analysis - Sutent’s US Patents Stymie Generic Challenge For Now
Industry Brief - ARIAD Updates On Final Recommendation By CHMP For Iclusig
Industry Brief - CHMP Recommends Xtandi For Treating Chemotherapy-Naïve MCRPCA
Industry Brief - Health Canada Approves Trintellix For Adults With MDD
Industry Brief - The Medicines Company Sees US Angiomax Patent Victory
Industry Trend Analysis - Push For Ebola Vaccines Likely Not Fast Enough For Current Epidemic
Industry Brief - Amgen Files Alirocumab Lawsuit Against Sanofi/Regeneron
Industry Trend Analysis - Taiho Aims For Swift Entry To US MCRC Market
Industry Brief - Sanofi/Regeneron Initiate Dupilumab Phase III Study In Atopic Dermatitis
Industry Brief - BI Initiates Global Phase III Study Of Nintedanib In Advanced CRC

Table Of Contents

Key Pharma News 03 NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.